ALK and lung adenocarcinoma: This leads to consider the need for studies that enhance the molecular changes that, like EGFR, K-ras and ALK genes for lung adenocarcinoma, at prognostic and/or predictive levels may give chances for an effective therapeutic response in these patients [4].